Credit Suisse’s Boston Scientific BSX Stock Holding History

Credit Suisse’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75,000	Closed	-$3.25M	–	4506
2021 Q3	$3.25M	Sell	75,000 -3,100	-4%	-$137K	﹤0.01%	2410
2021 Q2	$3.38M	Sell	78,100 -38,100	-33%	-$1.6M	﹤0.01%	2423
2021 Q1	$4.49M	Sell	116,200 -329,700	-74%	-$12.5M	﹤0.01%	2161
2020 Q4	$16M	Buy	+445,900	New	+$16.1M	0.01%	1301
2020 Q2	–	Sell	-33,400	Closed	-$1.09M	–	3962
2020 Q1	$1.09M	Buy	+33,400	New	+$1.3M	﹤0.01%	2589
2019 Q4	–	Sell	-72,000	Closed	-$2.93M	–	4164
2019 Q3	$2.93M	Buy	+72,000	New	+$3.05M	﹤0.01%	2174
2018 Q4	–	Sell	-135,000	Closed	-$5.2M	–	3874
2018 Q3	$5.2M	Buy	+135,000	New	+$4.72M	﹤0.01%	1673
2018 Q1	–	Sell	-118,400	Closed	-$2.94M	–	3967
2017 Q4	$2.94M	Hold	118,400	–	–	﹤0.01%	2145
2017 Q3	$3.45M	Buy	+118,400	New	+$3.27M	﹤0.01%	2085

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's BSX Position: Q1 2024 in Review

Credit Suisse reduced its Boston Scientific (BSX) stake by 3% in Q1 2024, selling an estimated $4.04M and leaving 2,058,101 shares worth $141M. The position accounts for 0.13% of the portfolio, ranked #142.

Credit Suisse first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Credit Suisse held 2,058,101 shares of Boston Scientific worth $141M as of Q1 2024.
Credit Suisse sold 62,865 Boston Scientific shares in Q1 2024, an estimated $4.04M.
Boston Scientific made up 0.13% of Credit Suisse's portfolio in Q1 2024, its #142 holding.
Credit Suisse first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.